Aclaris Therapeutics, Inc. (ACRS)
4.40
+1.78
(+67.94%)
USD |
NASDAQ |
Jan 20, 16:00
4.45
+0.05
(+1.14%)
After-Hours: 17:19
Aclaris Therapeutics Price: 4.40 for Jan. 20, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Corcept Therapeutics, Inc. | 35.28 |
| Puma Biotechnology, Inc. | 6.615 |
| Nephros, Inc. | 5.00 |
| Prelude Therapeutics, Inc. | 1.845 |
| Vivos Therapeutics, Inc. | 1.97 |
Price Related Metrics
| PS Ratio | 32.35 |
| PEG Ratio | -0.0191 |
| Price to Book Value | 3.969 |
| Earnings Yield | -31.40% |
| Market Cap | 476.72M |
| PEGY Ratio | -0.0191 |